Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study.

Abstract

ERT with low-dose imiglucerase (+/- 10 U/kg/fortnight) ameliorates Gaucher disease-associated anaemia and thrombocytopenia. Low-dose ERT is effective and may be considered in resource-poor clinical situations when other alternatives are not available.